Risk of serious adverse event and fatal adverse event with molecular target anticancer drugs in cancer patients: A meta-analysis | J Cancer Res Ther; 2020 Jan; 15(6): 1435-1449 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Risk of serious adverse event and fatal adverse event with molecular target anticancer drugs in cancer patients: A meta-analysis

Wang, Zhiwei; Yang, Xiao; Wang, Jitao; Wang, Shuai; Mao, Xiaorong; Li, Mingxing; Yongzhao, Zhao; Weidong, Wang; Xiaolong, Qi; Tongwei, Wu.

J Cancer Res Ther ; 2020 Jan; 15(6): 1435-1449

Article | IMSEAR | ID: sea-213553

Key words

Cancer; fatal adverse event; molecular target anticancer therapy; serious adverse event

Search on Google

Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article